The recent market advance linked to artificial intelligence is no longer confined to a small group of mega-cap technology firms and the semiconductor supply chain. What began as a concentrated rally has widened, producing notable breakouts across healthcare, energy, financials and industrials at the same time.
Market participants point to a combination of factors behind the broadened move. President Trump’s decision to call off planned strikes on Iran provided a near-term boost to risk appetite, while institutional money rotating into sectors that had lagged the earlier AI-driven surge has helped lift a broad array of equities.
Members of InvestingPro who subscribe to the monthly model-driven lists have been positioned ahead of several of June’s strongest performers. Those members captured more than a dozen names with double-digit gains before a wider market rotation unfolded, according to the subscription service’s reporting.
Several of the June selections moved past the 20% mark before the month was half over. In one session alone, Marvell Technology rose 11.1% and Veeco added 8.5%, while another semiconductor equipment stock jumped 12.7% in one of the period’s largest single-day moves - underscoring that the chip-related trade remains active.
Notable performers through June to date include:
- Marvell Technology (NASDAQGS:MRVL): +27.93% in June ALONE
- Amneal Pharmaceuticals (NASDAQGS:AMRX): +26.67% in June ALONE
- Veeco (NASDAQGS:VECO): +24.98% in June ALONE
- Murphy USA (NYSE:MUSA): +20.63% in June ALONE
- Haemonetics (NYSE:HAE): +18.77% in June ALONE
- Onto Innovation (NYSE:ONTO): +18.70% in June ALONE
The subscription program highlights the complete list of June picks to members. In addition to the mid-month winners above, the service reports that more than 25 selections have already moved beyond 5% gains within the first two weeks of the month, with winners spread across industrials, financials and energy as well as healthcare and consumer names.
Why the semiconductor equipment rally still has momentum - a closer look at Onto Innovation
Onto Innovation’s breakout is emblematic of the specific, data-driven signals the model looks for. Before the company’s recent surge, the machine learning engine that supplies the ProPicks lists identified Onto as a buy for a confluence of quantitative and fundamental reasons. The rationale reported by the model included:
- Momentum with apparent upside: Despite an approximately 87% year-to-date gain and roughly 144% appreciation over the past year as the stock reached record highs, the shares still traded meaningfully below top Wall Street price targets of $350, suggesting runway under analyst projections.
- Revenue acceleration: Annual revenue surpassed the $1 billion threshold, with a faster growth trajectory. Management issued Q2 2026 guidance of $320–$330 million, indicating sequential revenue growth driven largely by demand for advanced packaging.
- Critical qualification: TSMC qualified Onto’s Dragonfly G5 inspection platform for its AI chip packaging lines, positioning Onto as a default tool supplier for advanced fabs and supporting projected product-line growth of over 50% this year.
- Earnings leverage: Strong operating leverage produced earnings growth projected at about 27%, allowing margins to expand faster than revenue and keeping valuation appealing on a forward-growth basis despite prior gains.
Those data points formed the core of the model’s buy signal prior to the stock’s breakout, according to the ProPicks reporting.
Short-term winners and longer-term compounding gains
While June’s immediate winners are notable, the subscription service also highlights longer-term compounded gains on picks made over time. Examples cited include several names that have delivered outsized returns since selection:
- Consensus Cloud Solutions (NASDAQGS:CCSI): +63.39% since chosen
- Nucor (NYSE:NUE): +62.35% since chosen
- Haemonetics (NYSE:HAE): +46.39% since chosen
- Molina Healthcare (NYSE:MOH): +42.25% since chosen
- Cardinal Health (NYSE:CAH): +41.77% since chosen
- Texas Instruments (NASDAQGS:TXN): +40.07% since chosen
The service argues that consistently selecting and holding high-conviction ideas through their growth cycles has driven outperformance. Since the formal launch of the ProPicks AI strategy in November 2023, the reported cumulative return is +217.22%, ahead of the S&P 500 by +142.89% over the same span. The figures are presented as model-recorded performance from the official launch date.
How the model chooses its monthly lists
Each month the proprietary AI evaluates a broad universe of global equities using a mix of historical inputs, valuation metrics and growth projections. The process described includes:
- Processing more than 15 years of financial history across in excess of 150 quantitative models.
- Identifying up to 20 high-conviction stocks per strategy based on projected medium-term upside potential.
- Applying a strict monthly rebalancing regimen - adding new prospects, retaining strong performers and removing stocks that no longer meet criteria.
- Using equal weighting across selected stocks within each strategy to provide a transparent benchmark for model performance, with individual investors free to alter allocations as they see fit.
The stated objective is to keep capital allocated to companies that combine momentum, attractive valuation and improving business performance.
Observations
The broadening of the AI-driven rally into multiple sectors suggests that institutional buyers are extending their exposure beyond the initial set of beneficiaries. Semiconductor and hardware names continue to lead in absolute moves, but healthcare, energy, consumer-facing and industrial companies have joined the advance, resulting in a more diverse set of breakout candidates.
For investors following model-driven lists, the key takeaway is the combination of clearly articulated selection criteria and monthly rebalancing, which together aim to capture both short-term breakouts and longer-term compounding gains.